Furthermore, other factors which could influence the credibility of our results are the various etiologies of dACLD among our study group, since such medical conditions as NAFLD or NASH alone bias irisin secretion, even without intercurrent end-stage liver disease. This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatohepatitis.